American Academy of Dermatology-68th annual meeting. 5-9 March 2010, Miami Beach, FL, USA.
The American Academy of Dermatology, held in Miami Beach, FL, USA, included topics covering new therapeutic and diagnostic developments in the field of dermatological diseases. This conference report highlights selected presentations on melanoma, including genetic risk factors, improvements in detection, molecular classification and targeting BRAF mutations, and on psoriasis, including the immunology of psoriasis, biological therapies and psoriasis as a systemic illness.
Whang
Talley
T
Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029-6574, USA. talley.whang@mountsinai.org
Goldenberg
Gary
G
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D016503:Drug Delivery Systems; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use; D008545:Melanoma / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D009154:Mutation; D048493:Proto-Oncogene Proteins B-raf / Q000187:drug effects; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology; D012307:Risk Factors; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics
D000970:Antineoplastic Agents; D007155:Immunologic Factors; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf